IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV12I7A152

Percutaneous occlusion of the left atrial appendage with complex anatomy facilitated with 3D-printed model of the heart

Radoslaw Pracon1, MD, PhD; Roman Grygoruk2, Eng PhD; Zofia Dzielinska1, MD, PhD; Cezary Kepka1, MD, PhD; Agnieszka Dąbrowska1; Marek Konka3, MD, PhD; Przemysław Jazwiec4, MD, PhD; Krzysztof Reczuch5, MD, PhD; Adam Witkowski6, MD, PhD; Marcin Demkow1, MD, PhD

An 84-year-old female with paroxysmal atrial fibrillation, CHA2DS2-VASc score 4, HAS-BLED score 3, developed subdural haematoma on warfarin and was qualified for left atrial appendage occlusion (LAAO). The first attempt at LAAO was abandoned due to complex appendage anatomy with a large-sized landing zone and chicken-wing shape. This prompted obtaining a 3D-printed polyamide model of the heart (Panel A-Panel F). Rehearsals were undertaken in the model with 31 mm and 34 mm ACP Amulet™ devices (St. Jude Medical, St. Paul, MN, USA) (Online Figure 1). Contrary to the sizing chart, assessment of the devices’ position in the model indicated the 31 mm device as optimal, while a stable position could not be achieved with the 34 mm device. A 31 mm device was delivered to the patient but a leak was noted (Online Figure 2A, Online Figure 2B). Experience with the 3D model guided operators on device redeployment with counterclockwise rotation of the sheath (Online Figure 2C, Online Figure 2D) and complete appendage sealing (Online Figure 3).

Acknowledgements

St. Jude Medical provided sheaths and left atrial appendage occluders for rehearsals in the 3D-printed model free of charge.

Conflict of interest statement

R. Pracon has received speaker’s honoraria from St. Jude Medical. M. Demkow is a proctor for St. Jude Medical. The other authors have no conflicts of interest to declare.

Supplementary data

Online Figure 1. Attempts to occlude the appendage in the 3D-printed model. A) - C) 31 mm, well-fitted device. D) - F) 34 mm, oversized device.

Online Figure 2. Intraprocedural imaging and computed tomography with superimposed, draft device position. A) & B) After the first deployment (arrow indicates suboptimal position of superior device’s edge and a leak). C) & D) After device redeployment (arrow indicates optimal device position without the leak).

Online Figure 3. Post-procedural imaging. A) Fluoroscopy. B) Transoesophageal echocardiography. C) Computed tomography (CT). D) 3D CT reconstruction.

Moving image 1. Angiography of the left atrial appendage.

Moving image 2. First deployment of the 31 mm ACP Amulet device’s lobe.

Moving image 3. First deployment of the 31 mm ACP Amulet device’s disc.

Moving image 4. Angiography after the first deployment of the 31 mm ACP Amulet device in the left atrial appendage with visible leak over the superior portion of the device.

Moving image 5. Counterclockwise rotation of the sheath and second deployment of the 31 mm ACP Amulet device’s lobe.

Moving image 6. Second deployment of the 31 mm ACP Amulet device’s disc.

Moving image 7. Final angiography after the second deployment of the 31 mm ACP Amulet device in the appendage; no visible leak over the superior portion of the device.

Moving image 8. The 31 mm ACP Amulet device in the appendage after its release from the delivery cable.

Supplementary data

To read the full content of this article, please download the PDF.

Angiography of the left atrial appendage.

First deployment of the 31 mm ACP Amulet device’s lobe.

First deployment of the 31 mm ACP Amulet device’s disc.

Angiography after the first deployment of the 31 mm ACP Amulet device in the left atrial appendage with visible leak over the superior portion of the device.

Counterclockwise rotation of the sheath and second deployment of the 31 mm ACP Amulet device’s lobe.

Second deployment of the 31 mm ACP Amulet device’s disc.

Final angiography after the second deployment of the 31 mm ACP Amulet device in the appendage; no visible leak over the superior portion of the device.

The 31 mm ACP Amulet device in the appendage after its release from the delivery cable.

Volume 12 Number 7
Sep 18, 2016
Volume 12 Number 7
View full issue


Key metrics

Suggested by Cory

CLINICAL RESEARCH

10.4244/EIJ-D-17-00970 Jun 20, 2018
Left atrial appendage occlusion simulation based on three-dimensional printing: new insights into outcome and technique
Ciobotaru V et al
free

Image – Interventional flashlight

10.4244/EIJ-D-21-00731 Jun 24, 2022
Simulation-based planning of transcatheter left atrial appendage occlusion
Perrin N et al
free

Image – Interventional flashlight

10.4244/EIJ-D-21-00624 Jun 3, 2022
Percutaneous left atrial appendage closure in a surgically ligated left atrial appendage
Wong I et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV12I2A44 Jun 10, 2016
The plug for the appendage
Buellesfeld L et al
free

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free

CLINICAL RESEARCH

10.4244/EIJV11I13A292 Apr 20, 2016
Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach
Tzikas A et al
free

10.4244/EIJV12SXA10 May 16, 2016
Left atrial appendage closure: patient, device and post-procedure drug selection
Tzikas A and Bergmann M
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
38.95

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved